Largest health care pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 health care pharmaceutical companies ranked by revenue, at ZAR 1.65T, ahead of Eli Lilly (ZAR 1.14T) and Merck & Co (ZAR 1.14T). Figures as of 20 Nov 2026, 09:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonZAR 1.65T
- Median
- ZAR 56B
- Combined market value
- ZAR 86.74T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | ZAR 1.65T | ZAR 11.24T | ZAR 4,669.54 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | ZAR 1.14T | ZAR 21.04T | ZAR 23,617.21 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | ZAR 1.14T | ZAR 5.72T | ZAR 2,321.48 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | ZAR 1.09T | ZAR 2.74T | ZAR 481.39 | 1.85% down | 15% up | ||
| 5 | AbbVieABBV · Health Care | ZAR 1.07T | ZAR 8.76T | ZAR 4,956.20 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | ZAR 1.03T | ZAR 4.76T | ZAR 3,066.12 | 1.87% down | 1% up | ||
| 7 | NovartisNVS · Health Care | ZAR 953.2B | ZAR 4.99T | ZAR 2,643.28 | 2.57% down | 25% up | ||
| 8 | SanofiSNY · Health Care | ZAR 846.1B | ZAR 1.93T | ZAR 805.12 | 2.25% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | ZAR 842.4B | ZAR 2.08T | ZAR 1,019.77 | 2.05% down | 30% up | ||
| 10 | Novo NordiskNVO · Health Care | ZAR 801.7B | ZAR 2.99T | ZAR 679.44 | 1.42% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | ZAR 774.8B | ZAR 3.14T | ZAR 1,815.62 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | ZAR 757.9B | ZAR 1.68T | ZAR 835.88 | 1.56% down | 5% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | ZAR 493.3B | ZAR 1.2T | ZAR 374.24 | 0.66% up | 51% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 301.7B | ZAR 786.1B | ZAR 673.67 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 250.7B | ZAR 1.67T | ZAR 16,139.73 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | ZAR 250B | ZAR 398.4B | ZAR 347.50 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 209.8B | ZAR 2.31T | ZAR 9,101.00 | 2.94% down | 27% up | ||
| 18 | ZoetisZTS · Health Care | ZAR 165.5B | ZAR 573.8B | ZAR 1,412.19 | 5.59% down | 26% down | ||
| 19 | GrifolsGRFS · Health Care | ZAR 145.9B | ZAR 97.6B | ZAR 143.33 | 3.19% down | 0% up | ||
| 20 | BeOne MedicinesONC · Health Care | ZAR 93.4B | ZAR 798.1B | ZAR 6,986.65 | 0.97% down | 16% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | ZAR 82.4B | ZAR 229.7B | ZAR 459.54 | 1.54% down | 26% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 74.6B | ZAR 265.3B | ZAR 4,133.08 | 4.57% down | 41% up | ||
| 23 | GenmabGMAB · Health Care | ZAR 65B | ZAR 553.4B | ZAR 897.58 | 0.75% up | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 64.9B | ZAR 346.1B | ZAR 2,583.85 | 1.06% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 62.5B | ZAR 216.1B | ZAR 259.22 | 1.00% down | 8% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 56.3B | ZAR 208B | ZAR 1,073.61 | 0.02% down | 17% up | ||
| 27 | United TherapeuticsUTHR · Health Care | ZAR 55.6B | ZAR 416.2B | ZAR 9,772.92 | 3.16% down | 22% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 52.8B | ZAR 130.3B | ZAR 373.89 | 2.24% down | 90% up | ||
| 29 | Royalty PharmaRPRX · Health Care | ZAR 41.6B | ZAR 680.6B | ZAR 1,183.73 | 1.38% down | 79% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | ZAR 30.3B | ZAR 85.2B | ZAR 1,019.51 | 3.16% down | 21% down | ||
| 31 | AlkermesALKS · Health Care | ZAR 25.8B | ZAR 135.6B | ZAR 807.21 | 1.43% down | 66% up | ||
| 32 | Legend BiotechLEGN · Health Care | ZAR 18B | ZAR 54.6B | ZAR 281.42 | 0.92% down | 41% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 16.8B | ZAR 161.1B | ZAR 6,934.91 | 0.34% down | 27% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | ZAR 16.5B | ZAR 79.2B | ZAR 475.80 | 0.62% down | 63% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 14.5B | ZAR 107.9B | ZAR 762.99 | 1.25% up | 13% up | ||
| 36 | Ascendis PharmaASND · Health Care | ZAR 14B | ZAR 293.5B | ZAR 4,474.11 | 5.32% down | 29% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | ZAR 13.3B | ZAR 124.3B | ZAR 1,135.83 | 4.15% down | 10% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 11.8B | ZAR 128.5B | ZAR 1,634.97 | 1.59% down | 129% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | ZAR 11.2B | ZAR 124.7B | ZAR 2,371.65 | 1.25% up | 6% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | ZAR 10.8B | ZAR 171.4B | ZAR 1,134.08 | 1.88% down | 117% up | ||
| 41 | InsmedINSM · Health Care | ZAR 10.6B | ZAR 554B | ZAR 2,525.12 | 20.58% up | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 9.1B | ZAR 109B | ZAR 1,669.49 | 3.27% up | 34% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | ZAR 8.8B | ZAR 266.2B | ZAR 1,366.57 | 0.22% up | 21% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | ZAR 8.6B | ZAR 81B | ZAR 844.27 | 3.86% down | 45% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | ZAR 4.7B | ZAR 100.3B | ZAR 5,015.63 | 3.94% down | 50% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 3.3B | ZAR 141.5B | ZAR 2,041.63 | 1.88% down | 18% up | ||
| 47 | CytokineticsCYTK · Health Care | ZAR 1.5B | ZAR 125.3B | ZAR 899.51 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | ZAR 804.3M | ZAR 141.5B | ZAR 2,167.84 | 2.47% down | 51% up | ||
| 49 | Roivant SciencesROIV · Health Care | ZAR 144.4M | ZAR 493.4B | ZAR 681.01 | 0.59% up | 91% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | ZAR 35.6M | ZAR 83.5B | ZAR 1,482.81 | 1.01% up | 108% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | ZAR 0 | ZAR 162.1B | ZAR 1,706.55 | 3.77% down | 332% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | ZAR 0 | ZAR 151.9B | ZAR 5,434.45 | 1.87% up | 86% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4797 ZAR). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by revenue?
Johnson & Johnson (ZAR 1.65T), Eli Lilly (ZAR 1.14T) and Merck & Co (ZAR 1.14T) are the top three of the 52 health care pharmaceutical companies ranked by revenue as of 20 Nov 2026, 09:40 UTC.
How many health care pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 52 health care pharmaceutical companies ranked by revenue have a combined market value of ZAR 86.74T as of 20 Nov 2026, 09:40 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.